Health Care [ 8/12 ] | Pharmaceuticals [ 50/74 ]
NASDAQ | Common Stock
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America, China and Australia.
It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products.
Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 17, 25 | -0.34 | - |
| Jun 30, 25 | -0.38 | - |
| Nov 15, 24 | -0.14 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 24 | N/A Decreased by -100.00% | -1.13 M Increased by +8.37% | - - |
| Jun 30, 24 | 0.00 Decreased by N/A% | -1.13 M Decreased by -385.46% | Decreased by N/A% - |
| Mar 31, 24 | 0.00 - | -727.42 K - | Decreased by N/A% - |
| Jun 30, 23 | -1.00 - | -947.83 K - | Increased by +94.78 M% - |
| Jun 30, 22 | 147.54 K - | -1.24 M - | Decreased by -838.21% - |
| Jun 30, 21 | N/A - | -233.41 K - | - - |